Protective aspects for atherogenesis and lipid abnormalities in continuous ambulatory peritoneal dialysis patients.
Nakagawa
S
S
Tokyo Metropolitan Tama Geriatric Hospital, Japan.
Ozawa
K
K
D000368:Aged; D000369:Aged, 80 and over; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D003404:Creatinine / Q000097:blood; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D017270:Lipoprotein(a) / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008760:Methylguanidine / Q000097:blood; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D011341:Probucol / Q000627:therapeutic use; D012307:Risk Factors; D012643:Selenium / Q000097:blood; D013482:Superoxide Dismutase / Q000097:blood
D017270:Lipoprotein(a); D008315:Malondialdehyde; D008760:Methylguanidine; D003404:Creatinine; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D012643:Selenium; D011341:Probucol